Showing 1 - 20 results of 1,158 Refine Results
  1. 1
    Academic Journal

    Source: IEEE Solid-State Circuits Letters IEEE Solid-State Circuits Lett. Solid-State Circuits Letters, IEEE. 8:29-32 2025

    Linked Full Text
  2. 2
    Conference

    Source: 2023 IEEE International Conference on Contemporary Computing and Communications (InC4) Contemporary Computing and Communications (InC4), 2023 IEEE International Conference on. 1:1-7 Apr, 2023

    Relation: 2023 IEEE International Conference on Contemporary Computing and Communications (InC4)

  3. 3
  4. 4
  5. 5
  6. 6
    Conference

    Source: 2023 IEEE International Conference on Integrated Circuits and Communication Systems (ICICACS) Integrated Circuits and Communication Systems (ICICACS), 2023 IEEE International Conference on. :1-5 Feb, 2023

    Relation: 2023 IEEE International Conference on Integrated Circuits and Communication Systems (ICICACS)

  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
    Academic Journal
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
    eBook

    Contributors: Cassano, Enrico, Pesapane, Filippo

    Subject Terms: ductal carcinoma in situ (DCIS), invasive breast carcinoma, breast, biopsy, overtreatment, active surveillance, Contrast-Enhanced Mammography (CEM), Dynamic Contrast Magnetic Resonance Imaging (DCE-MRI), radiomics, artificial intelligence, breast tumor segmentation, convolutional neural network, deep learning, X-ray images, breast cancer, brain metastasis, tissue-specific metastasis, organotropism, cancer metabolism, oxidative phosphorylation (OXPHOS), mitochondria, cyclooxygenase 7b (Cox7b), hereditary breast cancer, cancer susceptibility genes, PALB2, aberrant splicing, functional assay, minigenes, clinical interpretation, cyclin-dependent kinase inhibitor 4 and 6, HER2-low, palbociclib, circulating tumor cells, neoplastic cells, circulating, neoplasms/diagnosis, circulating/pathology, breast neoplasms/pathology, biomarkers, tumor, blood, liquid biopsy, AhR, agonist, ligand, TCDD, triple-negative breast cancer, exploratory subgroup discovery, chemoimmunotherapy, bone metastases, bone scan, follow-up, prognosis, survival, SETD7, molecular subtypes, gene expression, biological processes, HER2, antibody-drug conjugate, trastuzumab-deruxtecan, T-Dxd, communication, decision-making, patient empowerment, ONEST, observers needed to evaluate subjective tests, TILs, sTILs, tumour-infiltrating lymphocytes, triple-negative, reproducibility, international immuno-oncology biomarker working group, European Working Group for Breast Screening Pathology, breast-conserving surgery, radiation, de-escalation, early breast cancer, metastatic breast cancer, BRCA, NGS, HRD score, homologous recombination deficiency, mutational signature, PARPi, platinum salts, metastasis, secretome, immune modulation, tumor microenvironment, drug resistance, therapeutic targets, precision oncology, Medicine and Nursing, Diseases and disorders, Oncology

    File Description: application/octet-stream

  20. 20